Lorena Gracia-Simon
Tartu, 50411, Estonia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy.
Journal: Scientific reports
Published: February 05, 2024
Targeting of Tomato Bushy Stunt Virus with a Genetically Fused C-End Rule Peptide.
Journal: Nanomaterials (Basel, Switzerland)
Published: March 07, 2023
ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 13, 2022
Preclinical Validation of Tumor-Penetrating and Interfering Peptides against Chronic Lymphocytic Leukemia.
Journal: Molecular pharmaceutics
Published: February 03, 2022
Homing Peptide-Based Targeting of Tenascin-C and Fibronectin in Endometriosis.
Journal: Nanomaterials (Basel, Switzerland)
Published: October 20, 2021
Bi-Functional Peptides as a New Therapeutic Tool for Hepatocellular Carcinoma.
Journal: Pharmaceutics
Published: September 06, 2021
Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics.
Journal: Pharmaceutics
Published: July 11, 2021
Novel Anthracycline Utorubicin for Cancer Therapy.
Journal: Angewandte Chemie (Weinheim an der Bergstrasse, Germany)
Published: December 11, 2020
Novel Anthracycline Utorubicin for Cancer Therapy.
Journal: Angewandte Chemie (International ed. in English)
Published: December 11, 2020
Neuropilin-1 is a host factor for SARS-CoV-2 infection.
Journal: Science (New York, N.Y.)
Published: June 14, 2020
iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity.
Journal: Journal of nanobiotechnology
Published: May 13, 2019
Last Updated: 09/26/2026